from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2655c/-

LFCtreatmentdescriptionclass of inhibitor

0.031

Amikacinug/mL Amikacintranslation

-0.228

Cap5-10ug/mL Capreomycintranslation

-0.482

Rox10-50 ug/mL Roxithromycintranslation

0.060

SM2-5 ug/mL Streptomycintranslation

1.290

Tet5-10 ug/mL Tetracyclinetranslation

0.185

Rif0.2-5ug/mL Rifampicintranscription

-0.055

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.056

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.506

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.543

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.357

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.248

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.954

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.842

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.124

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.366

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.003

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.019

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.020

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.596

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.390

Nigericin50 uM Nigericinrespiration

-0.027

TRC10-150 ug/mL Triclosanrespiration

0.159

TRZ10-25 ug/mL Thioridazinerespiration

3.933

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.453

menadione6-10 ug/mL Menadionerespiration

-0.109

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.449

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.546

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.184

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.041

NRP_1Non-replicating persistence stage 1dosRassociated

-0.648

Amp0.2mg/mL AmpicillincellWall

-0.222

Cephalexin20-100 ug/mL CephalexincellWall

0.006

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.501

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.346

EMB10-20 ug/mL EthambutolcellWall

0.521

Eta12-40 ug/mL EthionamidecellWall

-0.417

INH0.2-0.4 ug/mL IsoniazidcellWall

0.013

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.958

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.851

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.091

BZA0.12 mg/mL BenzamidearomaticAmides

0.207

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.301

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.196

H2O24 mM hydrogen peroxideDNAdamaging

-0.320

Levo10 ug/mL LevofloxacinDNAdamaging

0.631

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.585

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.287

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.209

UVUV-irradiationDNAdamaging

-1.085

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.082

Antimycin12.5-50 ug/mL Antimycin A?

-0.859

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.010

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.231

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.627

PA8240.2-2 ug/mL PA-824?

0.359

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.082

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.753

Verapamil50 uM Verapamil?

-1.373

mercaptoethanol2 mM 2-Mercaptoethanol?

0.023

methoxatin10-20 ug/mL Methoxatin?